Overall, we demonstrate that TSN contributes to NSCLC chemoresistance by facilitating the expression of S100A11, which in turn inhibits phospholipase A2, leading to a decrease in mitochondrial superoxide production, thus suppressing mitochondrial superoxide-dependent apoptotic cell death. This evidence concerns the gene PLA2G4A and non-small cell lung carcinoma.